… responses against different tumor cells. Currently, Listeria monocytogenes vaccine alone is
… underlying the involvement of Listeria monocytogenes vaccine in anti-tumor immunity, and …

… responses capable of challenging cancer recurrence. This … to cancer vaccination, employing
Listeria monocytogenes vectors, … Listeria monocytogenes (Lm) is a Gram-positive bacteria …

… monocytogenes (Lm)-based vaccines. This review will cover the important developments
leading up to the application of Lm in tumor immunotherapy (… for tumor immunotherapy and the …

… tumor immunotherapy programs that target breast cancer. In one, we are using Listeria
monocytogenes … active form on up to 60% of human breast tumors [44]. Because Her-2/neu is …

… Killing of tumor cells and cross-presentation. (1)Listeria monocytogenes secreting a tumor
… cells, which then present peptides derived from Listeria through MHC I and II molecules. (2) …

… of Listeria monocytogenes and its virulence factors as cancer immunotherapeutics. We
describe their development as vectors to carry protein tumor … efforts to harness their tumor-homing …

… Listeria monocytogenes is a Gram-positive intracellular … monocytogenes can activate a
robust cell-mediated immune response that is being harnessed as an immunotherapeutic platform…

… with Listeria monocytogenes vaccines [10]. The possibilities of successful Listeria monocytogenes
cancer … will contribute to innovative anti-cancer therapies that benefit cancer patients. …

… In this review, we provide a brief background of Listeria monocytogenes as a vaccine …
Listeria-based immunotherapies, and detail the advancements in development of improved Listeria…

… to successfully treat HPV-associated cancer. Intracellular bacteria are able to generate a …
Our lab and those of others have demonstrated the ability of Listeria monocytogenes to be …